Zydus

Pharma Stocks Surge After US Senate Passes Biosecure Act

Pharma stocks gained momentum on December 19 as the US Senate approved the Biosecure Act, a key provision within the fiscal 2026 National Defense Authorization Act (NDAA). This move, aimed at limiting certain Chinese biotech companies from receiving federal funding, sparked a positive reaction ac...